Autoimmune hepatitis - Update 2015

Journal of Hepatology

Volumn 62, Issue S1, 2015, Pages S100-S111

  Manns, Michael P ^a   Lohse, Ansgar W ^b   Vergani, Diego ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Immunosuppression; Transplantation; Treg

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; BUDESONIDE;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; CHRONIC HEPATITIS; DELTA AGENT HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE SYSTEM; IMMUNOADSORBENT; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY; TREATMENT FAILURE; HEALTH CARE QUALITY; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; LIVER; LIVER TRANSPLANTATION; PATHOLOGY;

BUDESONIDE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER TRANSPLANTATION; STANDARD OF CARE; TREATMENT FAILURE;

EID: 84944412749     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.03.005     Document Type: Review

References (86)

1. J. Waldenstrom Liver, blood proteins and food proteins Dtsch Z Verdau Stoffwechselkr 12 1952 113 121
2. I.R. Mackay, L.I. Taft, and D.C. Cowling Lupoid hepatitis Lancet 271 1956 1323 1326
3. A.P. Kirk, S. Jain, S. Pocock, H.C. Thomas, and S. Sherlock Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis Gut 21 1980 78 83
4. P. Muratori, A. Granito, C. Quarneti, S. Ferri, R. Menichella, F. Cassani, and et al. Autoimmune hepatitis in Italy: the Bologna experience J Hepatol 50 2009 1210 1218
5. R. Liberal, M.S. Longhi, G. Mieli-Vergani, and D. Vergani Pathogenesis of autoimmune hepatitis Best Pract Res Clin Gastroenterol 25 2011 653 664
6. P.T. Donaldson Genetics of liver disease: immunogenetics and disease pathogenesis Gut 53 2004 599 608
7. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, E.L. Cancado, and et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
8. Y. Ma, D.P. Bogdanos, M.J. Hussain, J. Underhill, S. Bansal, M.S. Longhi, and et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2 Gastroenterology 130 2006 868 882
9. I. Djilali-Saiah, R. Renous, S. Caillat-Zucman, D. Debray, and F. Alvarez Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients J Hepatol 40 2004 904 909
10. Y.S. de Boer, N.M. van Gerven, A. Zwiers, B.J. Verwer, B. van Hoek, K.J. van Erpecum, and et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1 Gastroenterology 147 2014 e445
11. K. Agarwal, A.J. Czaja, D.E. Jones, and P.T. Donaldson Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis Hepatology 31 2000 49 53
12. M.J. Simmonds, and S.C. Gough Genetic insights into disease mechanisms of autoimmunity Br Med Bull 71 2004 93 113
13. A. Liston, S. Lesage, D.H. Gray, R.L. Boyd, and C.C. Goodnow Genetic lesions in T-cell tolerance and thresholds for autoimmunity Immunol Rev 204 2005 87 101
14. A. Vogel, H. Liermann, A. Harms, C.P. Strassburg, M.P. Manns, and P. Obermayer-Straub Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1 Hepatology 33 2001 1047 1052
15. T.O. Lankisch, E. Jaeckel, and C.P. Strassburg The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1 Semin Liver Dis 29 2009 307 314
16. T.O. Lankisch, C.P. Strassburg, D. Debray, M.P. Manns, and E. Jacquemin Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases J Pediatr 146 2005 839 842
17. M.P. Manns, K.J. Griffin, K.F. Sullivan, and E.F. Johnson LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase J Clin Invest 88 1991 1370 1378
18. M. Holdener, E. Hintermann, M. Bayer, A. Rhode, E. Rodrigo, G. Hintereder, and et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection J Exp Med 205 2008 1409 1422
19. M. Hardtke-Wolenski, K. Fischer, F. Noyan, J. Schlue, C.S. Falk, M. Stahlhut, and et al. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells Hepatology 58 2013 718 728
20. M. Hardtke-Wolenski, R. Taubert, F. Noyan, M. Sievers, J. Dywicki, J. Schlue, and et al. Autoimmune hepatitis in a murine APS-1 model is directed against multiple autoantigens Hepatology 2014 [epub ahead]
21. M. Lenzi, S. Bellentani, G. Saccoccio, P. Muratori, F. Masutti, L. Muratori, and et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort Gut 45 1999 435 441
22. N. Kerkar, K. Choudhuri, Y. Ma, A. Mahmoud, D.P. Bogdanos, L. Muratori, and et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease J Immunol 170 2003 1481 1489
23. F.D. Mackie, M. Peakman, M. Yun, R. Sallie, H. Smith, E.T. Davies, and et al. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus Gastroenterology 106 1994 1672 1675
24. S. Pischke, A. Gisa, P.V. Suneetha, S.B. Wiegand, R. Taubert, J. Schlue, and et al. Increased HEV seroprevalence in patients with autoimmune hepatitis PLoS One 9 2014 e85330
25. A.W. Lohse, P. Obermayer-Straub, G. Gerken, S. Brunner, U. Altes, H.P. Dienes, and et al. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease - possible association with a steroid-resistant transplant rejection episode J Hepatol 31 1999 149 155
26. E. Bjornsson, J. Talwalkar, S. Treeprasertsuk, P.S. Kamath, N. Takahashi, S. Sanderson, and et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis Hepatology 51 2010 2040 2048
27. M.S. Longhi, Y. Ma, D.P. Bogdanos, P. Cheeseman, G. Mieli-Vergani, and D. Vergani Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease J Hepatol 41 2004 31 37
28. M.S. Longhi, Y. Ma, R.R. Mitry, D.P. Bogdanos, M. Heneghan, P. Cheeseman, and et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis J Autoimmun 25 2005 63 71
29. S. Ferri, M.S. Longhi, C. De Molo, C. Lalanne, P. Muratori, A. Granito, and et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis Hepatology 52 2010 999 1007
30. R. Taubert, M. Hardtke-Wolenski, F. Noyan, A. Wilms, A.K. Baumann, J. Schlue, and et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies J Hepatol 61 2014 1106 1114
31. M. Peiseler, M. Sebode, B. Franke, F. Wortmann, D. Schwinge, A. Quaas, and et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency J Hepatol 57 2012 125 132
32. G. Senaldi, B. Portmann, A.P. Mowat, G. Mieli-Vergani, and D. Vergani Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis Arch Dis Child 67 1992 1447 1453
33. M.P. Manns, A.J. Czaja, J.D. Gorham, E.L. Krawitt, G. Mieli-Vergani, D. Vergani, and et al. Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
34. V.J. Desmet, M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer Classification of chronic hepatitis - Diagnosis, grading and staging Hepatology 19 1994 1513 1520
35. M.I. Johnson Pj Meeting report: International Autoimmune Hepatitis Group Hepatology 18 1993 998 1005
36. E.M. Hennes, M. Zeniya, A.J. Czaja, A. Pares, G.N. Dalekos, E.L. Krawitt, and et al. Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176
37. D. Vergani, F. Alvarez, F.B. Bianchi, E.L. Cancado, I.R. Mackay, M.P. Manns, and et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group J Hepatol 41 2004 677 683
38. G. Mieli-Vergani, and D. Vergani Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis 29 2009 297 306
39. D.P. Bogdanos, P. Invernizzi, I.R. Mackay, and D. Vergani Autoimmune liver serology: current diagnostic and clinical challenges World J Gastroenterol 14 2008 3374 3387
40. D.P. Bogdanos, G. Mieli-Vergani, and D. Vergani Autoantibodies and their antigens in autoimmune hepatitis Semin Liver Dis 29 2009 241 253
41. P.L. Meroni, and P.H. Schur ANA screening: an old test with new recommendations Ann Rheum Dis 69 2010 1420 1422
42. G.F. Bottazzo, A. Florin-Christensen, A. Fairfax, G. Swana, D. Doniach, and U. Groeschel-Stewart Classification of smooth muscle autoantibodies detected by immunofluorescence J Clin Pathol 29 1976 403 410
43. T. Philipp, M. Durazzo, C. Trautwein, B. Alex, P. Straub, J.G. Lamb, and et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D Lancet 344 1994 578 581
44. O. Crivelli, C. Lavarini, E. Chiaberge, A. Amoroso, P. Farci, F. Negro, and et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent Clin Exp Immunol 54 1983 232 238
45. C.P. Strassburg, P. Obermayer-Straub, B. Alex, M. Durazzo, M. Rizzetto, R.H. Tukey, and et al. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis Gastroenterology 111 1996 1576 1586
46. P. Lapierre, O. Hajoui, J.C. Homberg, and F. Alvarez Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis Gastroenterology 116 1999 643 649
47. M. Manns, G. Gerken, A. Kyriatsoulis, M. Staritz, and K.H. Meyer zum Buschenfelde Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen Lancet 1 1987 292 294
48. M. Baeres, J. Herkel, A.J. Czaja, I. Wies, S. Kanzler, E.L. Cancado, and et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics Gut 51 2002 259 264
49. I. Wies, S. Brunner, J. Henninger, J. Herkel, S. Kanzler, K.H. Meyer zum Buschenfelde, and et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis Lancet 355 2000 1510 1515
50. M. Costa, J.L. Rodriguez-Sanchez, A.J. Czaja, and C. Gelpi Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis Clin Exp Immunol 121 2000 364 374
51. S. Palioura, R.L. Sherrer, T.A. Steitz, D. Soll, and M. Simonovic The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation Science 325 2009 321 325
52. C. Gelpi, E.J. Sontheimer, and J.L. Rodriguez-Sanchez Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion Proc Natl Acad Sci U S A 89 1992 9739 9743
53. E.L. Krawitt Autoimmune hepatitis N Engl J Med 354 2006 54 66
54. A.W. Lohse, and G. Mieli-Vergani Autoimmune hepatitis J Hepatol 55 2011 171 182
55. K.H. Meyerzumbuschenfelde, A.W. Lohse, M. Manns, and T. Poralla Autoimmunity and liver-disease Hepatology 12 1990 354 363
56. P.J. Johnson, and I.G. McFarlane Meeting report: International Autoimmune Hepatitis Group Hepatology 18 1993 998 1005
57. A.W. Lohse Recognizing autoimmune hepatitis: scores help, but no more J Hepatol 54 2011 193 194
58. P. Muratori, A. Granito, G. Pappas, and L. Muratori Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients Hepatology 49 2009 1782 1783 author reply 1783
59. L. Munoz-Espinosa, G. Alarcon, A. Mercado-Moreira, P. Cordero, E. Caballero, V. Avalos, and et al. Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients Autoimmunity 44 2011 543 548
60. D.K. Qiu, Q.X. Wang, H. Wang, Q. Xie, G.Q. Zang, H. Jiang, and et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients J Hepatol 54 2011 340 347
61. K.M. Boberg, R.W. Chapman, G.M. Hirschfield, A.W. Lohse, M.P. Manns, and E. Schrumpf Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue J Hepatol 54 2011 374 385
62. H.P. Dienes, H. Popper, M. Manns, W. Baumann, W. Thoenes, and K.H. Meyerzumbuschenfelde Histologic features in autoimmune hepatitis Z Gastroenterol 27 1989 325 330
63. H.P. Dienes, H. Erberich, V. Dries, P. Schirmacher, and A. Lohse Autoimmune hepatitis and overlap syndromes Clin Liver Dis 6 2002 349 362 vi
64. A.J. Czaja, and H.A. Carpenter Autoimmune hepatitis with incidental histologic features of bile duct injury Hepatology 34 2001 659 665
65. Y. Zen, K. Notsumata, N. Tanaka, and Y. Nakanuma Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? Hum Pathol 38 2007 1669 1675
66. H. Hofer, C. Oesterreicher, F. Wrba, P. Ferenci, and E. Penner Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation J Clin Pathol 59 2006 246 249
67. E.M. Bayer, W. Herr, S. Kanzler, C. Waldmann, K.H. Meyer Zum Buschenfelde, H.P. Dienes, and et al. Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity J Hepatol 28 1998 803 811
68. S. Luth, J. Herkel, S. Kanzler, C. Frenzel, P.R. Galle, H.P. Dienes, and et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis J Clin Gastroenterol 42 2008 926 930
69. M.P. Manns, M. Woynarowski, W. Kreisel, Y. Lurie, C. Rust, E. Zuckerman, and et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
70. L. Muratori, P. Muratori, G. Lanzoni, S. Ferri, and M. Lenzi Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis Hepatology 52 2010 1857 author reply 1857-1858
71. A. Danielsson, and H. Prytz Oral budesonide for treatment of autoimmune chronic active hepatitis Aliment Pharmacol Ther 8 1994 585 590
72. J. Wiegand, A. Schuler, S. Kanzler, A. Lohse, U. Beuers, W. Kreisel, and et al. Budesonide in previously untreated autoimmune hepatitis Liver Int 25 2005 927 934
73. W. Hempfling, F. Grunhage, K. Dilger, C. Reichel, U. Beuers, and T. Sauerbruch Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis Hepatology 38 2003 196 202
74. M. Woynarowski, A. Nemeth, Y. Baruch, S. Koletzko, M. Melter, B. Rodeck, and et al. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents J Pediatr 163 2013 1347 1353
75. G. Mieli-Vergani, and D. Vergani Budesonide for juvenile autoimmune hepatitis? Not yet J Pediatr 163 2013 1246 1248
76. P.J. Johnson, I.G. McFarlane, and R. Williams Azathioprine for long-term maintenance of remission in autoimmune hepatitis N Engl J Med 333 1995 958 963
77. K. Zachou, N. Gatselis, G. Papadamou, E.I. Rigopoulou, and G.N. Dalekos Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients J Hepatol 55 2011 636 646
78. C. Weiler-Normann, C. Schramm, A. Quaas, C. Wiegard, C. Glaubke, N. Pannicke, and et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis J Hepatol 58 2013 529 534
79. K.W. Burak, M.G. Swain, T. Santodomingo-Garzon, S.S. Lee, S.J. Urbanski, A.I. Aspinall, and et al. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy Can J Gastroenterol 27 2013 273 280
80. G. Marceau, R. Yang, P. Lapierre, K. Beland, and F. Alvarez Low-dose anti-CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized mice Liver Int 35 2015 275 284
81. C. Schramm, M. Bubenheim, R. Adam, V. Karam, J. Buckels, J.G. O'Grady, and et al. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry Liver Transpl 16 2010 461 469
82. J.C. Duclos-Vallee, M. Sebagh, K. Rifai, C. Johanet, E. Ballot, C. Guettier, and et al. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence Gut 52 2003 893 897
83. N. Kerkar, R.A. Annunziato, L. Foley, J. Schmeidler, C. Rumbo, S. Emre, and et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem J Pediatr Gastroenterol Nutr 43 2006 629 634
84. C. Schramm, C. Weiler-Normann, C. Wiegard, S. Hellweg, S. Muller, and A.W. Lohse Treatment response in patients with autoimmune hepatitis Hepatology 52 2010 2247 2248
85. G. Mieli-Vergani, and D. Vergani De novo autoimmune hepatitis after liver transplantation J Hepatol 40 2004 3 7
86. M.P. Manns, and R. Taubert Treatment of autoimmune hepatitis Clin Liver Dis 1 2014 15 17